登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《IJSurgery，2月26日，World Health Organization declares Global Emergency: A review of the 2019 Novel Coronavirus (COVID-19)》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-02-27

  • World Health Organization declares Global Emergency: A review of the 2019 Novel Coronavirus (COVID-19)

    CatrinSohrabi，ZaidAlsafi，NiamhO’Neill，MehdiKhan，AhmedKerwan，AhmedAl-Jabir，ChristosIosifidis，RiazAgha

    https://doi.org/10.1016/j.ijsu.2020.02.034

    Abstract

    An unprecedented outbreak of pneumonia of unknown aetiology in Wuhan City, Hubei province in China emerged in December of 2019. A novel coronavirus was identified as the causative agent and was subsequently termed COVID-19 by the World Health Organization (WHO). Considered a relative of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), COVID-19 is a betacoronavirus that affects the lower respiratory tract and manifests as pneumonia in humans. Despite rigorous global containment and quarantine efforts, the incidence of COVID-19 continues to rise, with 50,580 laboratory-confirmed cases and 1,526 deaths worldwide. In response to this global outbreak, we summarise the current state of knowledge surrounding COVID-19.

  • 原文来源：https://www.sciencedirect.com/science/article/abs/pii/S1743919120301977
52浏览量
原文链接
相关报告

  • 《Am J Public Health，2月13日，Straining the System: Novel Coronavirus (COVID-19) and Preparedness for Concomitant Disasters》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-02-18
    • Straining the System: Novel Coronavirus (COVID-19) and Preparedness for Concomitant Disasters Nathaniel Smith , Michael Fraser PMID: 32053389 DOI: 10.2105/AJPH.2020.305618 Abstract Just a few weeks before the first confirmed case of novel coronavirus (COVID-19) was reported in the United States, the US Centers for Disease Control and Prevention (CDC) issued a bold promise to the nation: the agency will use its scientific expertise to bring a new level of preparedness in the United States and global health security against current and growing threats, finally eliminate certain diseases, and bring an end to the devastation of epidemics.1 The current outbreak of COVID-19 reminds us how urgent this promise is and just how critical it is to continue to sustain and strengthen our nation's public health infrastructure. The unprecedented pace of the public health response to COVID-19 has only been possible because of prior investments in public health preparedness. To accelerate our pace and meet the challenges of current and future health threats, we must advance our world-class data and analytics capabilities; maintain and expand our state-of-the-art public health laboratory capacity; continue building a workforce of trusted, expert, public health professionals; sustain our capacity to rapidly respond to outbreaks at their source; and assure a strong global and domestic preparedness capacity. (Am J Public Health. Published online ahead of print February 13, 2020: e1-e2. doi:10.2105/AJPH.2020.305618).
    29浏览量
    原文链接

  • 《Clinical Chemistry，3月12日，Emergence of a Novel Coronavirus Disease (COVID-19) and the Importance of Diagnostic Testing》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-03-14
    • Emergence of a Novel Coronavirus Disease (COVID-19) and the Importance of Diagnostic Testing: Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak Matthew J Binnicker Clinical Chemistry, hvaa071, https://doi.org/10.1093/clinchem/hvaa071 In late December 2019, Chinese health authorities investigated a cluster of atypical pneumonia cases occurring primarily in individuals who had visited a seafood and wet market in Wuhan, Hubei Province, China. Patients reported fever and cough, and most developed chest discomfort and/or respiratory distress, with a diagnosis of pneumonia being made by chest radiographs and/or computed tomographic (CT) scan (1,). After testing for common causes of respiratory infection yielded negative results, unbiased sequencing of bronchoalveolar lavage (BAL) fluid identified a variant beta-coronavirus with nearly 85% sequence homology to that of a bat severe acute respiratory syndrome (SARS)-like coronavirus (CoV) (1,). The virus was subsequently isolated in eukaryotic cell culture, and further characterization showed it to be distinct from SARS-CoV and Middle East respiratory syndrome (MERS)-CoV, with sequence homology of approximately 79% and about 50%, respectively (2,). The variant CoV, which has been named SARS-CoV-2 by the International Committee on Taxonomy of Viruses (3,), represents the seventh CoV to cause disease in humans, and the third CoV since 2003 to cross over from animals to humans and be associated with severe respiratory illness (1). The World Health Organization (WHO) has named the illness caused by SARS-CoV-2 coronavirus disease-2019 (COVID-19).
    50浏览量
    原文链接